Registry evaluating long-term outcomes of Transcatheter aortic valve replacement
a Multinational Multicenter Prospective Transpacific TAVR Registry
This study looks at how well Transcatheter Aortic Valve Replacement (TAVR) works for patients over time in real-life situations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 7 sites (Stanford, California and 6 other locations) |
| Trial ID | NCT03826264 on ClinicalTrials.gov |
What this trial studies
This registry assesses the long-term outcomes of patients undergoing Transcatheter Aortic Valve Replacement (TAVR) in real-world clinical settings. It is connected to the Asian TAVR registry, allowing for a comprehensive follow-up of subjects over a decade. The study aims to gather data that reflects the effectiveness and safety of TAVR procedures outside of controlled clinical trials.
Who should consider this trial
Good fit: Ideal candidates for this registry are all patients who are undergoing TAVR and can provide informed consent.
Not a fit: Patients who are not undergoing TAVR or cannot provide informed consent may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the long-term effectiveness and safety of TAVR, potentially improving patient outcomes.
How similar studies have performed: Other studies have shown success with similar observational approaches, particularly in evaluating long-term outcomes of TAVR.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients undergoing TAVR * Informed consent
Where this trial is running
Stanford, California and 6 other locations
- Stanford University — Stanford, California, United States (Recruiting)
- Northwestern Memorial Hospital — Chicago, Illinois, United States (Recruiting)
- Second Affiliated Hospital of Zhejiang University — Hangzhou, China (Recruiting)
- Bucheon Sejong Hospital — Bucheon-si, South Korea (Active_not_recruiting)
- Chungnam National University Hospital — Daejeon, South Korea (Recruiting)
- Asan Medical Center — Seoul, South Korea (Recruiting)
- Seoul National University Hospital — Seoul, South Korea (Completed)
Study contacts
- Principal investigator: Alan Ching Yuen Yeung, MD — Stanford University
- Study coordinator: Duk-woo Park, MD
- Email: dwpark@amc.seoul.kr
- Phone: 82230103995
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.